Latest Insider Transactions at Pro Mis Neurosciences Inc. (PMN)
This section provides a real-time view of insider transactions for Pro Mis Neurosciences Inc. (PMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ProMIS Neurosciences Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ProMIS Neurosciences Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 24
2024
|
Madge K. Shafmaster Director |
BUY
Open market or private purchase
|
Direct |
70,000
+25.15%
|
$70,000
$1.3 P/Share
|
|
Sep 23
2024
|
Madge K. Shafmaster Director |
BUY
Open market or private purchase
|
Direct |
70,000
+33.6%
|
$70,000
$1.28 P/Share
|
|
Sep 20
2024
|
Madge K. Shafmaster Director |
BUY
Open market or private purchase
|
Direct |
60,000
+46.75%
|
$60,000
$1.25 P/Share
|
|
Sep 17
2024
|
Michael S Gordon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
16,292
+14.88%
|
$16,292
$1.4 P/Share
|
|
Sep 16
2024
|
Michael S Gordon > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
76,931
+50.0%
|
$76,931
$1.22 P/Share
|
|
Aug 14
2024
|
Patrick D. Kirwin Director |
BUY
Open market or private purchase
|
Direct |
10,000
+13.7%
|
$10,000
$1.25 P/Share
|
|
Jul 31
2024
|
Jeremy M. Sclar > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
300,000
+9.99%
|
-
|
|
Jul 31
2024
|
Jeremy M. Sclar > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
697,674
+32.22%
|
-
|
|
Jul 31
2024
|
Michael S Gordon > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
500,000
+19.41%
|
-
|
|
Jul 31
2024
|
Michael S Gordon > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
465,116
+22.79%
|
-
|
|
Jul 31
2024
|
19 Promis Title > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
500,000
+19.41%
|
-
|
|
Jul 31
2024
|
19 Promis Title > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
465,116
+22.79%
|
-
|
|
Aug 23
2023
|
Max A. Milbury Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,297
+47.0%
|
-
|
|
Aug 23
2023
|
Neil Cashman Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,643
+8.59%
|
-
|
|
Aug 23
2023
|
Gavin T. Malenfant Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,660
+50.0%
|
-
|
|
Aug 23
2023
|
Patrick D. Kirwin Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+17.19%
|
-
|
|
Aug 23
2023
|
Gail M Farfel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,192
+49.08%
|
-
|
|
Dec 16
2022
|
Eugene Williams Director |
BUY
Open market or private purchase
|
Direct |
2,000
+0.62%
|
$8,000
$4.65 P/Share
|
|
Dec 15
2022
|
Patrick D. Kirwin Director |
BUY
Open market or private purchase
|
Indirect |
2,000
+6.67%
|
$8,000
$4.51 P/Share
|
|
Dec 14
2022
|
Gail M Farfel Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+33.33%
|
$4,000
$4.94 P/Share
|
|
Dec 13
2022
|
Patrick D. Kirwin Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+3.7%
|
$4,000
$4.87 P/Share
|
|
Dec 12
2022
|
Eugene Williams Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.63%
|
$5,000
$5.08 P/Share
|
|
Dec 09
2022
|
Patrick D. Kirwin Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+3.85%
|
$4,000
$4.98 P/Share
|
|
Dec 07
2022
|
Eugene Williams Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.63%
|
$5,000
$5.49 P/Share
|
|
Dec 06
2022
|
Gail M Farfel Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$5,000
$5.7 P/Share
|
|
Dec 02
2022
|
Eugene Williams Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.64%
|
$5,000
$5.98 P/Share
|
|
Aug 17
2022
|
Patrick D. Kirwin Director |
BUY
Open market or private purchase
|
Direct |
4,000
+8.7%
|
$20,000
$5.92 P/Share
|
|
Jul 11
2022
|
Eugene Williams Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.64%
|
$9,000
$9.8 P/Share
|